An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 7c18 that has a similar product distributed in the us, list number 1l82.
|
The customer reported a false positive architect (b)(6) result on a (b)(6) yr old male patient.Results provided: (b)(6) = 40 miu/ml, (b)(6) = > 250 iu/ml, (b)(6) = 12.6 s/co; immunochromatography: (b)(6) = positive, (b)(6) = negative.No impact to patient management was reported.
|
The complaint investigation for potential false reactive anti-hbs results included a search for similar complaints, and review of complaint text, trending data, labeling, and device history records.In-house testing of reagent lot 06510fn00 was completed.Return testing was not completed as returns were not available.Trending review determined no trends for the issue for the product.Device history record review on lot 06510fn00 did not show any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.In house testing of controls which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.Based on the investigation, no systemic issue or deficiency of the architect anti-hbs assay, lot number 06510fn00 was identified.
|